ArticleBMC public health2026
The economic burden and costs of suicide and self-harm in Sweden.
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSuicide and self-harm represent a major public health challenge with significant human and economic consequences. Quantifying its economic burden is essential for guiding preventive strategies and resource allocation.
methodsThis study estimated the societal costs of suicide and self-harm in Sweden in 2022 using data from high-quality national registries and publicly available sources. Costs encompassed direct costs (healthcare, emergency services, property damage) and indirect costs calculated using the human capital approach (productivity losses due to morbidity and premature death). Additionally, a monetary value for disability and death based on incidence data was used to monetize the burden of disease.
resultsThe total annual economic burden of suicide and self-harm in Sweden was substantial, amounting to approximately €970 million. Productivity losses from paid work represented the largest cost component, accounting for 67% of total costs, highlighting the considerable impact on the working-age population. When the monetary value of premature death and disability was estimated separately using a health-based valuation approach, the total burden increased to approximately €2.7 billion. Given the conservative assumptions applied in several components of the analysis, these estimates are likely to understate the true societal burden of suicide and self-harm.
conclusionsSuicide and self-harm impose a significant economic burden on Swedish society. Strengthening mental health services, workplace prevention programs, and postvention support could reduce both human suffering and societal costs. These findings provide valuable evidence to inform policymakers and stakeholders in designing cost-effective prevention strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.